; Oljačić, Slavica ; Petković, Miloš ; Type
Date issued
Results 1-20 of 20
| Issue Date | Title | Author(s) | Type | Мp-cat. |
|---|---|---|---|---|
| 2025 | Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents | Beljkaš, Milan ; Ružić, Dušan ; Djurić, Ana ; Vuletić, Ana ; Nchugoua Tchiehe, Guilaine; Jallet, Corinne; Cadet-Daniel, Veronique; Arimondo, Paola B; Santibanez, Juan F. ; Srdić-Rajić, Tatjana ;
Nikolić, Katarina
; Oljačić, Slavica ; Petković, Miloš ; | Article | 22M22 |
| 2025 | Discovery of (3-Phenylcarbamoyl-3,4-dihydro-2H-pyrrol-2-yl)phosphonates as Imidazoline I2 Receptor Ligands with Anti-Alzheimer and Analgesic Properties | Bagán, Andrea; López-Ruiz, Alba; Abás, Sònia; Ruiz-Cantero, Carmen M.; Vasilopoulou, Foteini; Taboada-Jara, Teresa; Griñán-Ferré, Christian; Pallàs, Mercè; Muguruza, Carolina; Diez-Alarcia, , Rebeca;
Callado, Luis F.; Entrena, José M.; Cobos, Enrique J.; Pérez, Belén; Morales-García, José A.; Molins, Elies; De Jonghe, Steven; Daelemans, Dirk; Brea, José; Val, C.; Loza, M. Isabel; Hernández-Hernández, Elena; García-Sevilla, Jesús A.; García-Fuster, M. Julia; Díaz, Caridad; Fernández-Godino, Rosario; Genilloud, Olga; Beljkaš, Milan
; Oljačić, Slavica ; Nikolić, Katarina ; Escolano, Carmen; | Article | 21a+M21a+ |
| 2025 | Određivanje strukture farmakofore, dizajn, sinteza i in vitro ispitivanje dualnih inhibitora histon deacetilaza (HDAC) i Rho-vezanih protein kinaza (ROCK) | Beljkaš, Milan | Doctoral theses | 70M70 |
| 2025 | Application of machine learning and molecular docking to the modelling and design of HDAC6/ROCK dual inhibitors with in vitro experimental validation | Beljkaš, Milan ; Zukić, Selma; Maran, Uko; Arimondo, Paola B; Petković, Miloš ; Oljačić, Slavica ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2025 | P 01 Identification of Dual-Acting HDAC Inhibitors for Pancreatic Cancer Treatment through Drug Synergy Predictions and Molecular Modeling | Đoković, Nemanja ; Ilić, Aleksandra ; Čebzan, Alen ; Radović, Branko ; Ružić, Dušan ; Beljkaš, Milan ; Đurić, Ana ; Srdić-Rajić, Tatjana ; Oljačić, Slavica ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2025 | Computer-Aided Drug Design of novel dual histone deacetylase inhibitors | Ilić, Aleksandra ; Beljkaš, Milan ; Čebzan, Alen ; Radović, Branko ; Đoković, Nemanja ; Nikolić, Katarina ; Oljačić, Slavica | Conference Paper | Mp. category will be shown later |
| 2025 | First Reported QSAR Models Of Dual HDAC6 And ROCK2 Inhibitors Employing Random Forest Regression Algorithm | Zukić, Selma; Beljkaš, Milan ; Maran, Uko; Petković, Miloš ; Nikolić, Katarina ; Oljačić, Slavica | Conference Paper | Mp. category will be shown later |
| 2024 | Molecular modeling and design of new PI3K/HDAC dual inhibitors | Beljkaš, Milan ; Kukić, E; Đoković, Nemanja ; Oljačić, Slavica | Conference Paper | Mp. category will be shown later |
| 2024 | Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design | Beljkaš, Milan ; Petković, Miloš ; Vuletić, Ana ; Đurić, Ana ; Santibanez, Juan F. ; Srdić-Rajić, Tatjana ; Nikolić, Katarina ; Oljačić, Slavica | Article | 21aM21a |
| 2024 | Strengthening the epigenetic and signaling axis: Dual HDAC/ROCK inhibitors as a new therapeutic strategy in cancer treatment | Beljkaš, Milan ; Petković, Miloš ; Ružić, Dušan ; Oljačić, Slavica ; Nikolić, Katarina ; Arimondo, Paola B; Srdić-Rajić, Tatjana ; Vuletić, Ana ; Jelić Mariokov Đurić, Ana | Conference Paper | Mp. category will be shown later |
| 2024 | Discovery of dual-acting HDAC inhibitors for the treatment of pancreatic cancer by combining drug synergy and molecular modeling | Đoković, Nemanja ; Ilić, Aleksandra ; Čebzan, Alen ; Radović, Branko ; Ružić, Dušan ; Beljkaš, Milan ; Đurić, Ana ; Srdić-Rajić, Tatjana ; Oljačić, Slavica ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2023 | Virtual docking and design of novel Histone deacetylase and Rho- associated protein kinases dual inhibitors (HDAC/ROCKs) | Beljkaš, Milan ; Petković, Miloš ; Nikolić, Katarina ; Oljačić, Slavica | Conference Paper | Mp. category will be shown later |
| 2023 | Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer | Beljkas, Milan ; Ilić, Aleksandra ; Cebzan, Alen ; Radović, Branko ; Đoković, Nemanja ; Ružić, Dušan ; Nikolić, Katarina ; Oljačić, Slavica | Article | 21aM21a |
| 2023 | Virtual Docking, design and in silico ADMET profiling of novel Rho- associated protein kinases-1 (ROCK1) inhibitors | Beljkaš, Milan ; Rebić, Jelena; Radan, Milica ; Đikić, Teodora ; Oljačić, Slavica ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2023 | 3D-Quantitative Structure-Activity Relationship and design of novel Rho- associated protein kinases-1 (ROCK1) inhibitors | Beljkaš, Milan ; Rebić, Jelena; Radan, Milica ; Đikić, Teodora ; Oljačić, Slavica ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2023 | Preclinical Evaluation of an Imidazole-Linked Heterocycle for Alzheimer’s Disease | Bagán, Andrea; Rodriguez-Arévalo, Sergio; Taboada-Jara, Teresa; Griñán-Ferré, Christian; Pallàs, Mercè; Brocos-Mosquera, Iria; Callado, Luis F.; Morales-García, José A.; Pérez, Belén; Diaz, Caridad;
Fernández-Godino, Rosario; Genilloud, Olga; Beljkaš, Milan
; Oljačić, Slavica ; Nikolić, Katarina ; Escolano, Carmen; | Article | 21aM21a |
| 2023 | 3D-Quantitative Structure-Activity Relationship approach in the design of novel Rho-associated protein kinases(ROCK) inhibitors | Beljkaš, Milan ; Oljačić, Slavica ; Petković, Miloš ; Nikolić, Katarina | Conference Paper | Mp. category will be shown later |
| 2022 | Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation | Ružić, Dušan ; Ellinger, Bernhard; Đoković, Nemanja ; Santibanez, Juan ; Gul, Sheraz; Beljkaš, Milan ; Đurić, Ana ; Ganesan, Arasu; Pavić, Aleksandar ; Srdić-Rajić, Tatjana ;
Petković, Miloš
; Nikolić, Katarina ; | Article | 21aM21a |
| 2022 | Anticancer evaluation of the selected tetrahydropyrimidines: 3D-QSAR, cytotoxic activities, mechanism of action, DNA, and BSA interactions | Milović Emilija ; Petronijević Jelena ; Joksimović Nenad ; Beljkaš M. ; Ružić D. ; Nikoletić Katarina ; Vraneš Milan ; Tot Aleksandar S. ; Đorđić Crnogorac Marija ; Stanojković Tatjana P. ;
Janković Nenad
; | Article | 22M22 |
| 2019 | Is there a borderline between cytotoxic and antimetastatic effects of selective Histone deacetylase 6 inhibitors in solid malignancies? | Nikolić, Katarina M. ; Ružić, Dušan B. ; Milan Beljkas ; Petković, Miloš R. ; Sheraz Gul; Juan F. Santibanez; Srdić-Rajić, Tatjana V. | Conference Paper | Mp. category will be shown later |